PFND vs REGN: Which Stock is Better?
Side-by-side comparison of Pathfinder Cell Therapy Inc and Regeneron Pharmaceuticals Inc in 2026
PFND
Pathfinder Cell Therapy Inc
—
REGN
Regeneron Pharmaceuticals Inc
$635.45
Key Metrics Comparison
| Metric | PFND | REGN | Winner |
|---|---|---|---|
| Market Cap | $14.01M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PFND
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PFND or REGN a better investment?
Comparing PFND and REGN: Pathfinder Cell Therapy Inc has a market cap of $14.01M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PFND and REGN?
PFND (Pathfinder Cell Therapy Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PFND or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PFND or REGN?
Both PFND and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PFND or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PFND or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $14.01M for PFND.
Should I buy PFND or REGN in 2026?
Both PFND and REGN have investment merit. PFND trades at $N/A while REGN trades at $635.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PFND and REGN stock?
Key differences: Market Cap ($14.01M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PFND or REGN in 2026?
The choice between PFND and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PFND and REGN?
PFND (Pathfinder Cell Therapy Inc) has a market cap of $14.01M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.